Browsing Tag
CDMO
40 posts
Oxford Biomedica (LSE: OXB) expands US manufacturing base with Durham viral vector facility buy
Find out how Oxford Biomedica’s new US viral vector facility strengthens its CDMO leadership and growth trajectory.
October 7, 2025
Québec and Ottawa unite to fund Delpharm’s Boucherville upgrade for hospital drug security
Find out how Delpharm’s C$220M investment is transforming its Boucherville plant into Canada’s sterile injectable powerhouse.
August 26, 2025
Torrent Pharmaceuticals to acquire J. B. Chemicals from KKR in INR 25,689 Cr deal: M&A to strengthen CDMO, IPM presence
Torrent Pharmaceuticals to acquire JB Pharma from KKR in INR 25,689 crore deal, followed by merger; aims to expand CDMO and India chronic segment leadership.
July 2, 2025
AtomVie Global Radiopharma partnering with TerraPower Isotopes to secure actinium-225 for global cancer therapy development
AtomVie Global Radiopharma signs agreement with TerraPower Isotopes to secure actinium-225 supply, aiming to advance CDMO-based cancer radiotherapies.
June 18, 2025
Glenmark Life Sciences is now Alivus Life Sciences: What this means for the pharma industry
Glenmark Life Sciences Limited, a prominent name in the pharmaceutical industry, has officially rebranded as Alivus Life Sciences…
January 19, 2025
Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling…
December 7, 2024
Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing…
November 9, 2024
Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and…
October 24, 2024
Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge
Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive…
July 26, 2024
Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief…
June 18, 2024